Sentences with phrase «other cognitive diseases»
Other cognitive diseases linked to paternal age include mental retardation of unknown etiology and Alzheimer's disease, and there is a strong relationship between paternal age and autism.»
http://www.schizophrenia.com/ Not exact matches
A Drink Might Boost Cognition and Creativity, and Potentially Fight Off the Flu A study published in the Journal of Alzheimer's Disease finds evidence that adults who drink moderately and regularly have a higher chance of not only living longer, but doing so without developing dementia or other cognitive impairment...
Research in the United States, Canada, Europe, and other developed countries, among predominantly middle - class populations, provides strong evidence that human milk feeding decreases the incidence and / or severity of diarrhea,1 - 5 lower respiratory infection,6 - 9 otitis media,3,10 - 14bacteremia, 15,16 bacterial meningitis, 15,17 botulism, 18 urinary tract infection, 19 and necrotizing enterocolitis.20, 21 There are a number of studies that show a possible protective effect of human milk feeding against sudden infant death syndrome,22 - 24insulin - dependent diabetes mellitus,25 - 27 Crohn's disease, 28,29 ulcerative colitis, 29 lymphoma, 30,31 allergic diseases,32 - 34 and other chronic digestive diseases.35 - 37 Breastfeeding has also been related to possible enhancement of cognitive development.38, 39
Many epidemiologic studies consistently show that breastfeeding not only provides optimal bio-avaiable nutrients, but also protects against diarrhoeal, respiratory and other diseases [11][12][13][14], including the non-communicable disease of obesity in later life [15][16][17] and leads to improved cognitive and psychosocial outcomes [18][19][20].
It is important for physicians and scientists to understand the unique pathology of HS - AGING, and to be able to differentiate it from other diseases, as it is only by making an accurate diagnosis that clinicians can hope to treat people who present with signs of cognitive decline.
Previous studies from Johns Hopkins and other centers have shown that people with Alzheimer's disease and severe cognitive decline have severe loss of serotonin neurons, but the studies did not show whether those reductions were a cause or effect of the disease.
The neuroprotective effects of nicotine were studied in a randomized clinical trial involving 67 subjects in the early stages of Alzheimer's disease, where memory was slightly impaired but decision - making and other cognitive abilities remained intact.
The Rice researchers found not only the positive link between inhibition and diabetes, but the absence of a link between other cognitive functions and the disease.
Accumulation of insoluble U1 protein was seen in samples from patients with mild cognitive impairment (MCI), a precursor stage to Alzheimer's, but the U1 pathology was not seen in any other brain diseases that were examined.
But Mucke, director of the Gladstone Institute of Neurological Disease at the University of California, San Francisco, and colleagues believe they may finally have pinpointed the cause of these puzzling personality twists as well as other cognitive deficits associated with Alzheimer's: petite mal (nonconvulsive) seizures similar to those exhibited in some types of epilepsy.
Cognitive performance and other clinical measures, including the United Parkinson Disease Rating Scale (UPDRS), Mini-Mental State Exam (MMSE), and Hoehn and Yahr scales, were assessed at the beginning of the study and subsequently every 6 months, with an average follow - up time of 1.8 years and maximum of 8 years.
The Centers for Disease Control and Prevention and the National Institute on Drug Abuse stress the potential for long - term cognitive impairment, problems with attention and coordination and other risk - taking behaviors due to heavy marijuana use.
B2M has also been found at increased levels in patients with Alzheimer's disease and other cognitive disorders.
However, they underscore that it is too soon to know whether regulating deltaFosB or calbindin could improve or prevent memory problems or other cognitive deficits in people with Alzheimer's disease.
«The distinct neural markers associated with cognitive performance and GWI revealed in our study can be useful for future research to objectively measure the efficacy of treatments for GWI as well as other brain disorders related to the same neurotransmitter system, like Alzheimer's disease.»
For instance, in addition to presiding over the long - running Leiden 85 - plus study, which tracks cognitive decline and risk factors for heart disease, stroke, and other illnesses in people 85 and older, Westendorp came up with an innovative and inexpensive way to explore the evolutionary tradeoff between longevity and fertility: analyzing old genealogical records of British aristocrats.
«More gray matter is associated with better cognitive function, while decreases in gray matter are associated with Alzheimer's disease and other related dementias,» said Shannon Halloway, PhD, the lead author of the Journal of Gerontology paper and the Kellogg / Golden Lamp Society Postdoctoral Fellow in the Rush University College of Nursing.
Other research studies have reported a decline in social networks in people with Alzheimer's disease and Mild Cognitive Impairment (MCI), and previous literature has shown psychological well - being in older age to be associated with reduced risk of developing Alzheimer's dementia.
Researchers have found a variant gene in schizophrenics that appears to be implicated in defective working memory and other cognitive problems that characterize the disease.
The precise mechanisms by which gum disease may be linked to cognitive decline are not fully clear and other factors might also play a part in the decline seen in participants» cognition alongside their oral health.
The most common type of dementia after Alzheimer's disease, it triggers strange and inappropriate behavior, especially in social situations, as well as difficulty with decision - making, language, and other cognitive functions.
As in prior studies among older adults, we found that obesity was associated with a decreased risk of dementia, consistent with the hypothesis that, while obesity in mid-life may increase risk for later - life cognitive decline and dementia, obesity at older ages may be associated with cognitive and other health advantages.25 - 27 The trend toward a declining risk for dementia in the face of a large increase in the prevalence of diabetes suggests that improvements in treatments between 2000 and 2012 may have decreased dementia risk, along with the documented declines in the incidence of common diabetes - related complications, such as heart attack, stroke, and amputations.11 Our finding of a significant decline between 2000 and 2012 of the heart disease - related OR for dementia would also be consistent with improved cardiovascular treatments leading to a decline in dementia risk.
The disease is characterized by profound fatigue and disability lasting for at least 6 mo, episodes of cognitive dysfunction, sleep disturbance, autonomic abnormalities, chronic or intermittent pain syndromes, microbiome abnormalities (1), cerebral cytokine dysregulation (2), natural killer cell dysfunction (3), and other symptoms that are made worse by exertion of any kind (4).
The most common cause of dementia is Alzheimer's disease, a progressive, irreversible brain disease that results in impaired cognitive functioning and other behavioural changes.
Abstract: While behavioral symptoms are both early and prevalent features of behavioral variant frontotemporal dementia (bvFTD), they can be present in other types of dementia as well, including Alzheimer's disease (AD) and even mild cognitive impairment (MCI).
While behavioral symptoms are both early and prevalent features of behavioral variant frontotemporal dementia (bvFTD), they can be present in other types of dementia as well, including Alzheimer's disease (AD) and even mild cognitive impairment (MCI).
I've written about the use of neuropsychological tests for the differential diagnosis of AD, MCI, normal cognitive aging, and other neurodegenerative diseases, as well as for the prediction of cognitive decline and conversion from MCI to dementia.
In particular, common neurological conditions such as stroke, Alzheimer's disease, Parkinson's disease and other chronic neurodegenerative diseases, age - related cognitive impairment, epilepsy, mood disorders and schizophrenia call for new therapeutic strategies.
These results suggest that the serotoninergic system may be not involved in the pathogenesis of depressive symptoms in AD patients, and it may be involved in other aspects of disease pathophysiology like cognitive symptoms and psychosis.
Background: In addition to other symptom domains, Huntington's disease (HD) is also characterized by cognitive disturbances that substantially diminish quality of life for both patients and caregivers.
Evidence that A beta immunization also reduces cognitive dysfunction in murine models of Alzheimer's disease would support the hypothesis that abnormal A beta processing is essential to the pathogenesis of Alzheimer's disease, and would encourage the development of other strategies directed at the «amyloid cascade».
Cholinergic neuron loss is a cardinal feature of Alzheimer's disease, a progressive brain disorder affecting memory, learning, attention and other cognitive processes.
«Jorge has developed a highly innovative research program focusing on the role of interneuron and network dysfunction in Alzheimer's disease and other cognitive disorders,» said Lennart Mucke, MD, director of the Gladstone Institute of Neurological Ddisease and other cognitive disorders,» said Lennart Mucke, MD, director of the Gladstone Institute of Neurological DiseaseDisease.
Brain Health Registry is a groundbreaking free, online platform designed to speed the path to cures for Alzheimer's disease, Parkinson's disease, depression, PTSD, mild cognitive impairment and other brain disorders.
Other research has suggested that supplementing might slow deterioration in cognition for people with Alzheimer's disease, but more research is needed on the effects of this antioxidant on cognitive function and brain health.
In other words, Hardman says, «the MedDiet offers the opportunity to change some of the modifiable risk factors» for cognitive decline, as well as other chronic diseases.
According to the Iranian researchers, the beneficial bacteria might potentially protect against Alzheimer's disease and other forms of cognitive decline, although more studies are needed.
«Starting younger does help prevent cognitive dysfunction and cerebrovascular disease later in life, and the younger we start exercising the better we can help temper effects of other lifestyle choices of the young such as drinking, eating pro-inflammatory foods, and poor sleep schedules,» she explains.
The deterioration and loss of synapses is linked to a number of neurodegenerative disorders and mental health problems, including Alzheimer's disease, depression, poor memory, intellectual impairment and other cognitive deficits (2 - 6).
Alzheimer's disease (AD) is a progressive form of dementia that destroys memories and other cognitive functions.
In addition to risk of problems involving lung function, selenium deficiency has been shown to increase our risk of heart failure and other forms of cardiovascular disease, as well as for other problems including type 2 diabetes, compromised cognitive function, and depression.
Studies have demonstrated that carnosine has many health benefits and can protect against heart diseases, diabetes, declining cognitive function and other associated aliments.
Antioxidant and anti-inflammatory, oleuropein can protect against cognitive decline, as well as Alzheimer's disease and other forms of dementia.
Successful and safe BHRT, however, necessitates laboratory testing to assess the patient's current hormonal status, monitor treatment, and ensure that hormones are being metabolized in ways that reduce risks for cancer, cardiovascular disease, osteoporosis, other age - related diseases and declines in cognitive and sexual function.
The primary driver of the disease pathology, and what's mainly responsible for the memory loss, cognitive impairment, personality changes and other signs and symptoms, is that neurons in affected regions of the brain become unable to effectively metabolize glucose.
In a study published in American Journal of Alzheimer's Disease and Other Dementias, researchers found that, although all berries imparted health benefits, strawberries and blueberries were the most effective in reducing cognitive decline.
«Given the high content of certain specific polyphenols in the juice blend, the increased antioxidant protection [in the body] after consumption of the juice blend, and the anti-inflammatory capacity in vitro, further research is warranted to evaluate whether juice blend consumption may provide reversal of risk markers in subjects with conditions such as arthritis, obesity, chronic viral diseases, cardiovascular disease and compromised cognitive function, as well as other conditions associated with chronic inflammation,» wrote lead author Gitte Jensen from Holger NIS Inc., a contract research laboratory.
Many Lyme symptoms, such as fatigue, cognitive impairment, joint pain, poor sleep, mood problems, muscle pain, and neurological presentations also occur in other diseases.
Other countries such as Japan and Europe have increased the lower limit for B12 to 500 - 550 pg / mL or 365 - 405 pmol / L because it is associated with improvements in behavioral and psychological symptoms including dementia, Alzheimer's disease, cognitive decline and memory loss.
Additionally, other areas were affected positively, as compared to the placebo group, who had taken the essential amino acids for lung disease (COPD), including improvements in: fat - free mass, serum albumin, increased muscle strength, oxygen saturation, and cognitive dysfunction.